A novel mutation in Sanfilippo Syndrome type B. Case report
Keywords:
Sanfilippo Syndrome type B, Mucopolysaccharidosis IIIB, NAGLU gene, alpha-N-acetylglucosaminidase.Abstract
Introduction: Sanfilippo syndrome type B is an autosomal recessive lysosomal storage disease. The frequent clinical manifestations include slightly coarse facial features, progressive neurodegeneration and mild somatic repercussion caused by mutations in the NAGLU gene, whose locus is 17q21.2. The worldwide incidence is very low and only seven patients have been diagnosed in Cuba since 1985.
Objective: To describe clinical, biochemical and molecular characteristics of a Cuban patient with the diagnosis of Sanfilippo Syndrome type B.
Case presentation: A 13 years old patient was described. The main clinical manifestations included mild coarse facie, synophrys, behavior disturbances, and progressive neurologic deterioration. Intermittent sleep disturbance and frequent upper respiratory infections were identified. Ulcerative colitis and intestinal polyp were demonstrated. Increased excretion of heparan sulfate and very low N-acetyl α-Dglucosaminidase activity were confirmed. In addition, the presence of mutation c.640dupC in NAGLU gene was identified. The patient had homozygous genotype and both parents were heterozygous.
Conclusions: Behavioral alterations, progressive neurological deterioration and respiratory infections predominated in the reported case. Other findings such as ulcerative colitis and intestinal polyps were not previously described in this disease. The chromatographic and enzymatic studies were positive for Sanfilippo type B. This patient's genotype was found to be homozygous for a novel pathogenic allelic variant in the NAGLU gene. Mendelian segregation of the mutation in the family was demonstrated.
Downloads
References
1. Sanfilippo SJ, Podosin R, Langer L, Good RA. Mental retardation associated with acid mucopolysacchariduria (heparitin sulfate type). J Pediatr [Internet]. 1963 [Citado 10/04/2020];63:837-8. Disponible en: http://dx.doi.org/10.1016/S0022-3476(63)80279-6
2. Baldellou A, Sanjurjo P, Del Toro M. Enfermedades Lisosomals. En: Sanjurjo P, Baldellou A. Diagnóstico y tratamiento de las enfermedades metabólicas hereditarias. 4 ed. Madrid: Ediciones Ergón; 2014.p. 861-95.
3. Pérez J, Ceberio L. Mucopolisacaridosis tipo III o Enfermedad de Sanfilippo. En: Guía para el manejo de las MPS [Internet]. Madrid: Ediciones Ergon; 2015 .p.48-58. [Citado 16/03/2020]. Disponible en: https://www.fesemi.org/sites/default/files/documentos/publicaciones/guia_manejo_mps.pdf
4. Whitley CB, Cleary M, Mengel K, Harmatz P, Shapiro E, Nestrasil I, et al. Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type B.J Pediatr [Internet]. 2018 [Citado 20/04/2020];197:198-206. Disponible en: https://doi.org/10.1016/j.jpeds.2018.01.044
5. Birrane G, DassierAL, Romashk A, Lundberg D, Holmes K, Cottle T, et al. Structural characterization of the α-N-acetylglucosaminidase, a key enzyme in the pathogenesis of Sanfilippo syndrome B. Journal of Structural Biology [Internet]. 2019 [Citado 22/04/2020];205:65-71. Disponible en: http://europepmc.org/article/MED/30802506
6. Giugliani R, Muñoz V, Cabello JF. Errores Innatos del Metabolismo Lisosomal. Parte 1: Mucopolisacaridosis. En: Colombo M, Cornejo V, Raimann E, eds. Errores Innatos del Metabolismo del niño. 4 ed. Santiago de Chile: Editorial Universitaria; 2017: 343-82.
7. Khan A, Peracha H,Ballhausen D, Wiesbauer A, Rohrbach M. Epidemiology of mucopolysaccharidoses. Mol Genet Metab [Internet]. 2017 [Citado 2/04/2020];121(3):227-40. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1096719217302068
8. Zhao HG, Li HH, Bach G, Schmidtchen A, Neufeld E.F. The molecular basis of Sanfilippo syndrome type. B Proc Nat Acad Sci [Internet]. 1996 [Citado 22/04/2020];93:6101-5. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC39196/
9. Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, et al. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. HumGenet [Internet]. 2017 [Citado 22/04/2020];136:665-77. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28349240
10. Menéndez C, González S, Peña M, Zaldívar C, González A. A Mucopolysaccharidosis: 20 years enzymatic diagnosis in Cuba. Rev Neurol [Internet]. 2009 [Citado 22/10/2020];49:458-62. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19859885/
11. Mokhtariye A, Hagh Nazari L, Varasteh AR,Keyfi F. Diagnostic methods for Lysosomal Storage Disease. Rep Biochem Mol Biol [Internet]. 2019 [Citado 4/05/2020];7(2):119-28. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374068/
12. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res [Internet]. 1988 [Citado 10/03/2020];16(3):1215-8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC334765/
13. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proceedings of the national academy of sciences [Internet]. 1977 [Citado 10/03/2020];74(12):5463-67. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC431765/
14. Zeng Q, Fan Y, Wang L, Huang Z, Gu X, Yu Y. Molecular defects identified by whole exome sequencing in a child with atypical mucopolysaccharidosis IIIB. J Pediatr Endocrinol Metab [Internet]. 2017 [Citado 12/05/2020];30(4):463-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28306536
15. Heon Roberts R, Nguyen AL, Pshezhetsky AV. Molecular Bases of Neurodegeneration and Cognitive Decline, the Major Burden of Sanfilippo Disease. J Clin Med [Internet]. 2020 [Citado 5/05/2020];9:344-59. Disponible en: https://www.mdpi.com/journal/jcm
16. Andrade F, Aldámiz Echevarría L, Llarena M, Couce ML.Sanfilippo syndrome: Overall review. Pediatr Int [Internet]. 2015 [Citado 5/05/2020];57(3):331-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25851924
17. De Ruijter J, Broere L, Mulder MF. Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease). J Inherit Metab Dis. [Internet]. 2013 [Citado 22/04/2020];37:447-54. Disponible en: https://europepmc.org/article/med/24173409
18. Hettiarachchi D, Nethikumara N, Arachchi B, Weththasigha K, Dilshani W, Dissanayake HW. A novel mutation in the NAGLU gene associated with Sanfilippo syndrome type B (mucopolysaccharidosis IIIB). Clinical Case Reports [Internet]. 2018 [Citado 12/05/2020];6(6):1051-4. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29881562
19. Weber B, Guo XH, Kleijer WJ, Van de Kamp JJP, Poorthuis BJM, Hopwood J J. Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinic phenotypes. Europ. J. Hum. Genet [Internet]. 1999 [Citado 10/08/2020];7(3):34-44. Disponible en:
https://pubmed.ncbi.nlm.nih.gov/10094189/
20. Karczewski KJ, Weisburd B, Thomas B, Solomonson M, Ruderfer DM, Kavanagh D, et al. The ExAC browser: displaying reference data information from over 60 000 exomes. Nucleic Acids Res [Internet]. 2017 [Citado 22/12/2020];45;D840-D845. Disponible en: https://doi:10.1093/nar/gkw971
21. Devuyst O. The 1000 Genomes Project Consortium. Nature [Internet]. 2015 [Citado 22/12/2020];526:68-74. Disponible en: https://doi.org/10.1038/nature15393
22. Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat [Internet]. 2011 [Citado 22/12/2020];32(5):557-63. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21520333/
23. Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods [Internet]. 2014 [Citado 22/12/2020];11(4):361-2. Disponible en: http://www.mutationtaster.org/